Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
J-Pharma announced a transition to an executive officer system to strengthen management and business execution, with Shinya Hirata newly appointed as executive officer in charge of clinical development and regulatory affairs.19d agoThe USFDA completed an inspection of Aurolife Pharma's Raleigh Plant in North Carolina, USA, from 24 March 2025 to 10 April 2025, issued a Form 483 with 11 observations, and subsequently closed the inspection with a Voluntary Action Indicated (VAI) classification.35d ago